Literature DB >> 9616487

The neuroleptic malignant syndrome: a logical approach to the patient with temperature and rigidity.

M V Balzan1.   

Abstract

The neuroleptic malignant syndrome is a rare, potentially fatal, adverse reaction to neuroleptic drugs characterised by severe rigidity, high temperature and autonomic dysfunction. In the light of the hypothesized pathophysiology of this condition, a rational approach to the management of patients presenting with temperature and rigidity is provided. The aims of this approach are three-fold: to reduce the incidence of the condition, to be able to recognise it early so as to treat before life-threatening complications arise, and to be able to recognise early those conditions which mimic neuroleptic malignant syndrome, so as not to delay their specific treatment.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9616487      PMCID: PMC2360818          DOI: 10.1136/pgmj.74.868.72

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  30 in total

1.  A prospective analysis of 24 episodes of neuroleptic malignant syndrome.

Authors:  P Rosebush; T Stewart
Journal:  Am J Psychiatry       Date:  1989-06       Impact factor: 18.112

2.  Risk factors for neuroleptic malignant syndrome. A case-control study.

Authors:  P E Keck; H G Pope; B M Cohen; S L McElroy; A A Nierenberg
Journal:  Arch Gen Psychiatry       Date:  1989-10

3.  Neuroleptic malignant syndrome: review and analysis of 115 cases.

Authors:  G Addonizio; V L Susman; S D Roth
Journal:  Biol Psychiatry       Date:  1987-08       Impact factor: 13.382

4.  Frequency and presentation of neuroleptic malignant syndrome: a prospective study.

Authors:  P E Keck; H G Pope; S L McElroy
Journal:  Am J Psychiatry       Date:  1987-10       Impact factor: 18.112

5.  Neuroleptic-induced extrapyramidal symptoms with fever. Heterogeneity of the 'neuroleptic malignant syndrome'.

Authors:  D F Levinson; G M Simpson
Journal:  Arch Gen Psychiatry       Date:  1986-09

6.  Catatonia: harbinger of the neuroleptic malignant syndrome.

Authors:  D A White; A H Robins
Journal:  Br J Psychiatry       Date:  1991-03       Impact factor: 9.319

7.  Electroconvulsive Therapy in the Treatment of the Neuroleptic Malignant Syndrome.

Authors:  John M. Davis; Philip G. Janicak; Paul Sakkas; Cindy Gilmore; Zhengyu Wang
Journal:  Convuls Ther       Date:  1991

8.  Electroconvulsive Therapy of the Lethal Catatonia Syndrome.

Authors:  Stephan C. Mann; Stanley N. Caroff; Henry R. Bleier; R. Eduardo Antelo; Hyong Un
Journal:  Convuls Ther       Date:  1990

9.  Paradoxical autonomic response to procyclidine in the neuroleptic malignant syndrome.

Authors:  M V Balzan
Journal:  Can J Neurol Sci       Date:  1995-08       Impact factor: 2.104

10.  Spectrum concept of neuroleptic malignant syndrome.

Authors:  S Singh; G Singh; S Ong
Journal:  Br J Psychiatry       Date:  1988-07       Impact factor: 9.319

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.